Mobile

A multicenter Phase III uncontrolled open-label trial to evaluate safety and efficacy of BAY 81-8973 in children with severe haemophilia A under prophylaxis therapy En multicenter fas III okontr...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021781-29

A multicenter Phase III uncontrolled open-label trial to evaluate safety and efficacy of BAY 81-8973 in children with severe haemophilia A under prophylaxis therapy En multicenter fas III okontrollerad öppen prövning för att utvärdera säkerheten och effekten av BAY 81-8973 hos barn med svår hemofili A enligt profylax behandling

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to evaluate the safety and efficacy of the treatment with BAY 81-8973 for prophylaxis and treatment of breakthrough bleeds in children with haemophilia A

Critère d'inclusion

  • Severe hemophilia A (< 1% FVIII:C)

Liens